Anti-infection Agents

Similar documents
Anti-infection Agents

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

2015 Antibiotic Susceptibility Report

2016 Antibiotic Susceptibility Report

EUCAST recommended strains for internal quality control

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Antimicrobial Susceptibility Testing: Advanced Course

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

ß-lactams. Sub-families. Penicillins. Cephalosporins. Monobactams. Carbapenems

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

General Approach to Infectious Diseases

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Chapter 46. Learning Objectives (cont d)

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

European Committee on Antimicrobial Susceptibility Testing

Antimicrobial susceptibility

3 party manufacturing PRODUCT LIST. Category : ANTI BIOTIC

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Antibiotic Updates: Part II

Cell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

number Done by Corrected by Doctor

Antimicrobial Susceptibility Patterns

** the doctor start the lecture with revising some information from the last one:

European Committee on Antimicrobial Susceptibility Testing

CONTAGIOUS COMMENTS Department of Epidemiology

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Antimicrobial Susceptibility Testing: The Basics

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

CONTAGIOUS COMMENTS Department of Epidemiology

56 Clinical and Laboratory Standards Institute. All rights reserved.

CONTAGIOUS COMMENTS Department of Epidemiology

January 2014 Vol. 34 No. 1

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

Approach to pediatric Antibiotics

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

* gender factor (male=1, female=0.85)

EUCAST-and CLSI potency NEO-SENSITABS

Antibiotic Usage Guidelines in Hospital

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Should we test Clostridium difficile for antimicrobial resistance? by author

What s new in EUCAST methods?

Penicillins - EUCAST clinical MIC breakpoints (version 1.3)

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

Antimicrobial Stewardship Program

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

number Done by Corrected by Doctor

Management of Hospital-acquired Pneumonia

Rational use of antibiotics

Antibiotics 1. Lecture 8

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

Other Beta - lactam Antibiotics

Infectious Disease: Drug Resistance Pattern in New Mexico

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

Concise Antibiogram Toolkit Background

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

Antimicrobial Therapy

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

British Society for Antimicrobial Chemotherapy

Dr. Shaiful Azam Sazzad. MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College

Rational management of community acquired infections

Intrinsic, implied and default resistance

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Advanced Practice Education Associates. Antibiotics

number Done by Corrected by Doctor Dr.Malik

Suggested treatment. Inj Crystalline Penicillin 50,000U/Kg i.v. 4-6hrly (if child cannot swallow) 40mg/Kg/dose BID x 10days

Rate In Rs.Ps (ED Included. Tax Extra) Sl No Name Of The Product Pack. Scheduled And Non-Scheduled Formulations Capsules

Monthly Webinar. Tuesday 12th December 2017, 16:00 Brewing Up a Little Storm. Event number: Audio dial-in (phone):

DR. BASHIRU BOI KIKIMOTO

Studies on Antimicrobial Consumption in a Tertiary Care Private Hospital, India

Antimicrobial Pharmacodynamics

RCH antibiotic susceptibility data

Provincial Drugs & Therapeutics Committee Memorandum Version 2

Health PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults

Transcription:

Pisutam (Lyo) Lyo for Inj. 2.25g 1 Pisutam (Lyo) Lyo for Inj. 4.5g 1 Pisutam Pow. for Inj. 2.25g 1 Pisutam Pow. for Inj. 4.5g 2 Picillina Pow. for Inj. 2g 2 Picillina Pow. for Inj. 4g 2 Ocillina Pow. for Inj. 0.5g 3 Ocillina Pow. for Inj. 1g 3 PenicillinV Tab. 400000U 3 Ansullina Pow. for Inj. 1.5g 4 Anbicyn Pow. for Inj. 0.6g 4 Anbicyn Pow. for Inj. 1.2g 4 Anbicyn F.C. Tablets 375mg 5 Anbicyn F.C.Tablets 625mg 5 Amoxicillin Cap. 500mg 5 Supecef Pow. for Inj. 0.5g 6 Supecef Pow. for Inj. 1g 6 Cefuroxime Pow. for Inj. 750mg 6 Tatumcef Pow. for Inj 0.5g 7 Tatumcef Pow. for Inj 1g 7 Tatumcef Pow. For Inj. 2g 7 Colirocin FCT. 250mg 8 Teicod Lyophilized 200 mg 9 Lyo-Vancin Lyophilized 500 mg 9 Myron Pow. for Inj. 0.25g 10 Myron Pow. for Inj. 0.5g 10

Culin Pow. for Inj. 0.25g 10 Culin Pow. for Inj. 0.5g 11 Leflodal F. C. Tab. 500 mg 12 Leflodal F. C. Tab. 100mg 12 Leflodal I.V. Solution 500mg/V 12 Ciflodal F.C. Tablets 500 mg 13 Oflodal F.C. Tablets 100mg 13 Azol-flucon I.V. Injection 2 mg/ml 14 Azol-flucon CAP. 50mg 14 Lisim Tab. 250mg 14 Acylete Tab. 400mg 15 Acylete Tab. 200mg 15 Sulbactam Pow. for Inj. 500mg 16 Clindamycin Cap. 150mg 16 Clindamycin Inj. 300mg 16 Hand Sanitizer Gel 60ml 17 Hand Sanitizer Gel 500ml 17 Hand Sanitizer Gel 3.8L 17 Anti-A Solution Solution 500ml 18 Hand Sanitizer Solution 500ml 18

Penicillins Pisutam (Lyo) R57 Lyo for Inj. 2.25g Pisutam (Lyo) R59 Lyo for Inj. 4.5g Pisutam K44 Pow. for Inj. 2.25g PIP-TZ PIP-TZ PIP-TZ Moderate to severe infections caused B-lactamase producing bacterial strains that aresusceptible to Piperacillin, have resistance to Piperacillin,but are susceptible to Piperacillin/Tazobactam. Moderate to severe infections caused B-lactamase producing bacterial strains that aresusceptible to Piperacillin, have resistance to Piperacillin,but are susceptible to Piperacillin/Tazobactam. Moderate to severe infections caused B-lactamase producing bacterial strains that aresusceptible to Piperacillin, have resistance to Piperacillin,but are susceptible to Piperacillin/Tazobactam. 2.25GM*10V AC510362CX 4.5GM*10V AC51036220 1 2.25GM*10V AC466872CX

Penicillins Pisutam Picillina Picillina K51 K36 K37 Pow. for Inj. Pow. for Inj. Pow. for Inj. 4.5g 2g 4g PIP-TZ Piperacillin Piperacillin Moderate to severe infections caused B-lactamase producing bacterial strains that are susceptible to Piperacillin, have resistance to Piperacillin, but are susceptible to Piperacillin/Tazobactam. Systemic and local infections caused by gram negative and positive anaerobic bacteria and obligate aerobic bacteria. Systemic and local infections caused by gram negative and positive anaerobic bacteria and obligate aerobic bacteria. 4.5GM*10V AC46687220 2GM*10V AC42828212 2 4GM*10V AC42828219

Penicillins Ocillina Ocillina PenicillinV K54 K53 D16 Pow. for Inj. Pow. for Inj. Tab. 0.5g 1g 400000U Oxacillin Oxacillin Penicillin Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. All symptoms caused by microbes susceptible to Penicillin.(Please IPC) 0.5GM*25V AC49000277 1GM*10V AC49000209 3 1000C/PTP/1000C/BTL NC024791G0

Penicillins Ansullina K38 Pow. for Inj. 1.5g Anbicyn P31 Pow. for Inj. 0.6g Anbicyn P30 Pow. for Inj. 1.2g Ampicillin/Subactam Amox/Clav Amox/Clav Infectious diseases induced by Streptococcus, Staphylococcus, E.coli, Klebsiela..(Please see IPC) Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. 1.5GM*10V AC42756210 600MG*10V AC42697280 4 1.2GM*10V AC42697297

Penicillins Anbicyn Anbicyn Amoxicillin E111 E103 B32 F.C. Tablets F.C.Tablets Cap. 375mg 625mg 500mg Amox/Clav Amox/Clav Amoxicillin Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, Meningococcus, and other susceptible bacteria. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcuspneumonia, Meningococcus, and other susceptible bacteria. 100T/PTP AC43952100 120T/PTP AC42660100 5 1000C/BTL AC24132100/AC241321G0

Cephalosporins Supecef Supecef Cefuroxime K55 K58 K25 Pow. for Inj. Pow. for Inj. Pow. for Inj. 0.5g 1g 750mg Cefepime Cefepime Cefuroxime Infectious diseases caused by bacteria susceptible to Cefepime. Infectious diseases caused by bacteria susceptible to Cefepime. Infectious diseases 0.5GM*10V A049147277 1GM*10V A049147209 6 750MG*25V A030620289

Cephalosporins Tatumcef Tatumcef Tatumcef K28 K31 K32 Pow. for Inj Pow. for Inj Pow. For Inj. 0.5g 1g 2g Ceftazidime Ceftazidime Ceftazidime It is a cephalosporin antibiotic, in resistant to ESBL, and is effective against both G (+)(-). It is a cephalosporin antibiotic, in resistant to ESBL, and is effective against both G (+)(-). It is a cephalosporin antibiotic, in resistant to ESBL, and is effective against both G (+)(-). 0.5GM*10V A038949277 1GM*5V A038949209 7 2GM*1V A038949212

Macrolides Colirocin E116 FCT. 250mg Clarithromycin Infectious diseases of the upper and lower airway caused by infectious bacteria. Can be used in conjunction with Omeprazole to treat duodenal ulcer associated with H. pylori. (Please see IPC) 28T/PTP;500T/BTL AC44733100 8

Glycopeptide Teicod Lyo-Vancin R53 R52 Lyophilized Lyophilized 200 mg 500 mg Teicoplanin vancomycin Endocarditis, osteomyelitis, pneumonia, septicemia, soft tissue infections, and enteritis caused by Staphylococcus infection; pseudomembranous colitis caused by Clostridium infection. Endocarditis, osteomyelitis, pneumonia, septicemia, soft tissue infections, and enteritis caused by Staphylococcus infection; pseudomembranous colitis caused by Clostridium infection. 3ML*VIAL AC47895263 500MG*10V AC47658277 9

Carbapenems Myron K46 Pow. for Inj. 0.25g Myron K48 Pow. for Inj. 0.5g Culin K56 Pow. for Inj. 0.25g Meropenem Meropenem Imipenem/Cilastatin Infectious diseases induced by Meropenem-susceptible bacteria. Infectious diseases induced by Meropenem-susceptible bacteria. Infectious diseases induced by Imipenem-susceptible gram negative and positive bacteria. 0.25GM*10V AC47828265 0.5GM*10V AC47828277 10 0.25GM*25V AC48189265

Carbapenems Culin K57 Pow. for Inj. 0.5g Imipenem/Cilastatin Infectious diseases induced by Imipenem-susceptible gram negative and positive bacteria. 0.5GM*25V AC48189277 11

Quinolones Leflodal Leflodal Leflodal E147 E146 P43 F. C. Tab. F. C. Tab. I.V. Solution 500 mg 100mg 500mg/V Levofloxacin Levofloxacin Levofloxacin Treatment infections in adults caused by Levofloxacin-susceptible pathogens. Please see IPC for more information. Airway infectious diseases, otorhinolaryngological diseases, UTI, uterine infections, etc. Please see IPC for more information. Treatment of the following infections in adults caused by Levofloxacinsusceptible pathogenic bacteria: CAP, UTI, SSSI, etc. Please see IPC for more information. 100T/PTP AC49696100 100T/PTP AC48694100 12 5mg/ml*100ml AC49651255

Quinolones Ciflodal Oflodal E81 E89 F.C. Tablets F.C. Tablets 500 mg 100mg Ciprofloxacin Ofloxacin Infections disease. (Please see IPC) Infectious diseases (Please see IPC) 80T/PTP;100T/BTL AC38528100 1000T/BTL AC39793100 13

Antifungal Agents Azol-flucon Azol-flucon Lisim P42 B51 D63 I.V. Injection CAP. Tab. 2 mg/ml 50mg 250mg Fluconazole Fluconazole Terbinafine Antifungal agent. Local or systemic Candida infection, Cryptococcic infection, prevention of fungal infections in AIDS patients. Onychomyosis, tineacapitis, and severe, wide spread dermatomycosis not responding to local treatment. 10 VIAL AC49002248 100C/PTP ; 3*12C/PTP AC41335100 14 14T/PTP;140T/PTP AC43575100

Antiviral Agents Acylete Acylete D54 D57 Tab. Tab. 400mg 200mg Acyclovir Acyclovir Infections induced by herpes zoster virus, skin and mucous membrane infections induced by herpes simplex virus. (Please see IPC) Infections induced by herpes zoster virus, skin and mucous membrane infections induced by herpes simplex virus.(please see IPC) 100T/BTL AC39315100 25T/BTL 100T/PTP AC40090100 15

Others Sulbactam Clindamycin Clindamycin K59 B38 M52 Pow. for Inj. Cap. Inj. 500mg 150mg 300mg Sulbactam Clindamycin Clindamycin A β-lactamase inhibitor, that have to combinate with Ampicillin. Treatment of Staphylococcus, Streptococcus, Streptococcus pneumonia, and other infectious bacteria susceptible to this drug. Infectious diseases caused by Staphylococcus, Streptococcus, Streptococcus pneumonia, anaerobic bacteria, and other susceptible bacteria. 500MG*10V A054647277 500C/BTL AC33457100 16 2ML*50A AC33572212

Others Hand Sanitizer Hand Sanitizer Hand Sanitizer F42 F42 F42 Gel Gel Gel 60ml 500ml 3.8L Ethylalcohol Ethylalcohol Ethylalcohol Skin and hand cleaning, disinfection, germicidal. Skin and hand cleaning, disinfection, germicidal. Skin and hand cleaning, disinfection, germicidal. 60ML/BTL 500ML/BTL 3.8L/BTL 17

Others Anti-A Solution Hand Sanitizer F06 F45 Solution Solution 500ml 500ml Benzalkonium Cl. Ethylalcohol Germicidal, disinfection. Skin and hand cleaning, disinfection, germicidal. 500ml 500ML/BTL 18